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Polyuria of thyrotoxicosis: Downregulation
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solute excretion
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Thyrotoxicosis is a common disorder causing cardiovascular
and renal irregularities. In this study, thyrotoxicosis was
produced in rats by 14 days of daily thyroxine injection.
This was associated with an increase in cardiac index, mean
arterial pressure, and renal blood flow compared with
euthyroid controls. Food and water intake along with urine
output were significantly increased in the thyrotoxic rats
compared with control animals associated with a significant
increase in solute excretion. Polyuria and increased solute
excretion still occurred even when food and water intake was
equivalent. These renal responses were associated with
significant decreases in AQP1 and AQP2 water channel
expression in both the ad lib and paired intake studies in the
cortex and inner medulla. The downregulation of AQP2
protein occurred in spite of equivalent plasma arginine
vasopressin (AVP) in the ad lib and increased AVP in the
paired feeding studies. Solute-free water reabsorption was
greater in both the ad lib and paired thyrotoxic than
euthyroid rats and was associated with increased Na–K–2Cl
cotransporter expression. We propose that the AVP-
independent downregulation of AQP2, the observed increase
in renal arterial pressure, and decrease in filtration fraction
contribute to polyuria the increased solute excretion in spite
of enhanced ion transporters in thyrotoxicosis.
Kidney International (2007) 72, 1088–1094; doi:10.1038/sj.ki.5002475;
published online 15 August 2007
KEYWORDS: hyperthyroidism; kidney; aquaporin; sodium transporter
Thyrotoxicosis is a common endocrine disorder in humans
and animals, which causes multiple changes in cardiovascular
and renal function.1 Hyperthyroidism is associated with a
hyperdynamic circulation including increased cardiac output
and blood pressure and decreased systemic vascular peri-
pheral resistance.2 These systemic hemodynamic alterations
are associated with increased renal hemodynamics and urine
flow.3,4 Both patients5 and animals6 with thyrotoxicosis may
demonstrate polydipsia and polyuria. The mechanisms for
the polyuria associated with thyrotoxicosis, however, have
not been well defined. Increased thirst and water intake could
be involved in the polyuria seen in hyperthyroidism. In this
regards, the sensation of thirst has been shown to occur at a
lower serum osmolality in thyrotoxicosis than the euthyroid
state.5,7 Alteration in systemic hemodynamics during hy-
perthyroidism could lead to non-osmotic suppression of
arginine vasopressin (AVP) with resulting polyuria. A role of
increased solute excretion, a known cause of polyuria, also
needs to be considered.3,4,8
The present investigations in thyrotoxic rats were under-
taken to examine the potential mechanisms of polyuria in
thyrotoxic rats including food and water intake, AVP, water
channels, ion transporters, and renal hemodynamics.
RESULTS
Hyperthyroidism was associated with increased cardiac,
mean arterial pressure, and renal hemodynamics
Hyperthyroidism was associated with marked increased heart
rate, cardiac index, mean arterial pressure (MAP), and pulse
pressure (Table 1). Importantly, renal blood flow (RBF) was
increased by 60% in hyperthyroidism (HT) rats as compared
with controls (CLT) (Table 1). To exclude effects of increased
food and water intake, protocol 2 was performed in which
food intake and water intake were the same between control
and HT rats. As observed in protocol 1, in protocol 2 MAP
was increased in HT rats (11774 vs 10273 mm Hg in
controls, P¼ 0.01) and RBF was significantly higher in HT
rats (n¼ 8) than that in controls (n¼ 6) (7.270.5 vs
5.270.3 ml/min, Po0.01). Filtration fraction was signifi-
cantly reduced to 50% of controls in HT rats (0.170.01 vs
0.270.03 in controls, Po0.01).
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Hyperthyroidism was associated with increased urine output
and increased urinary solute, urea, and sodium excretion
Protocol 1. Serum-free T4 measurement confirmed suc-
cessful induction of hyperthyroidism in HT rats (Table 2).
HT rats showed reduced body weight compared with controls
although their food and water intake increased. Relative renal
weights were significantly increased in HT rats (Table 2). No
significant differences were noted in serum osmolality, Na,
creatinine and urea concentrations, and 24–h creatinine
clearance. Urinary output in HT rats was significantly
increased as compared with controls (Table 2). Urinary
osmolar, urea, sodium excretion, and fractional sodium
excretion were significantly increased in response to thyrox-
ine administration. Solute-free water reabsorption (TcH2O)
was also significantly increased in HT rats (Table 2). In
protocol 1, there was no difference in plasma AVP
concentrations between HT (n¼ 7) and control groups
(n¼ 6) (0.970.1 vs 1.170.3 pg/ml in controls, P40.05).
Protocol 2. The polyuria still occurred in association with
increased urinary solute, urea, sodium excretion, and free
water reabsorption (Table 3). Urine output in HT rats started
to increase at day 12 compared with control rats and
persisted during the period of treatment (Figure 1). With
controlled water and food intake, plasma AVP level was
significantly increased in HT rats (n¼ 6) compared with
controls (n¼ 6) (2.170.5 vs 0.970.2 pg/ml in controls,
P¼ 0.01). Creatinine clearance was moderately decreased in
HT animals (Table 3).
Hyperthyroidism was associated with decreased AQP1 and
AQP2 abundance
Protocol 1. HT rats demonstrated a significant decrease in
AQP1 in the cortex and outer stripe of outer medulla (cortex/
OSOM; 8574 vs 10075% in controls, Po0.05, Figure 2a)
and inner medulla (IM; 8074 vs 10074% in controls,
Po0.01, Figure 2b), but not in inner stripe of outer medulla
(ISOM; 9075 vs 10076% in controls, P40.05). There was
also a significant decrease in AQP2 protein abundance in the
cortex/OSOM (8073 vs 10075% in controls, Po0.01),
ISOM (7275 vs 10075% in controls, Po0.01, Figure 3a),
Table 2 | Functional data on day 14 in control (CTL) and
hyperthyroidism (HT) rats after daily thyroxine injection
(protocol 1)
CTL (n=12) HT (n=15)
Body weight (g)
Before 18873 19372
After 28875 27173a
Serum-T4 (mg/dl) 570.3 (n=6) 1470.5b (n=9)
Food intake (g/day) 2271 2871b
Water intake (ml/day) 2471 3372b
KW/BW (%) 0.6870.01 0.9170.02b
Serum osmolality (mOsm/kgH2O) 29773 30073
Serum-Na (mmol/l) 14170.6 14370.8
Serum-creatinine (mg/dl) 0.3370.02 0.3570.03
Creatinine clearance (ml/min) 1.870.1 2.070.1
BUN (mg/dl) 1271 (n=6) 1271 (n=9)
Urine output (ml/min/kg) 1671 3073b
Urine osmolality (mOsm/kgH2O) 22707125 21747112
TcH2O (ml/min/kg) 10475 17779
b
UosmV (mOsm/ml/min) 3672 6273
b
UureaV (mg/kg/min) 325721 (n=6) 657723
b (n=9)
UNaV (mmol/kg/min) 3.070.2 4.870.2
b
FENa (%) 0.3570.02 0.4970.04
a
BUN, blood urea nitrogen; FENa: fractional excretion of sodium; KW/BW, ratio of
kidney weight to body weight; TcH2O: solute-free water reabsorption; UNaV, urinary
sodium excretion; UosmV, urinary osmolar clearance; UureaV, urinary urea clearance.
aPo0.01; bPo0.001; HT vs CTL.
Table 3 | Functional data on day 14 in control (CTL) and
hyperthyroidism (HT) rats after daily thyroxine injection
(paired study) (protocol 2)
CTL (n=12) HT (n=15)
Body weight (g)
Before 20476 20576
After 29076 25073a
Food intake (g/day) 1970.4 2070.1
Water intake (ml/day) 2270.5 2270.3
Serum osmolality (mOsm/kgH2O) 30072 30472
Serum-Na (mmol/l) 14170.6 14470.6a
Serum-creatinine (mg/dl) 0.3370.02 0.4370.02b
Creatinine clearance (ml/min) 2.170.2 1.570.1b
BUN (mg/dl) 1370.6 1470.6
Urine output (ml/min/kg) 1371.5 2172b
Urine osmolality (mOsm/kgH2O) 29427197 28277201
TcH2O (ml/min/kg) 10978 16075
a
UosmV (mOsm/ml/min) 3773 5572
a
UureaV (mg/kg/min) 504738 786727
a
UNaV (mmol/min/kg) 3.870.5 5.370.4
c
FENa (%) 0.3870.04 0.6570.07
b
BUN, blood urea nitrogen; FENa, fractional excretion of sodium; T
c
H2O: solute-free
water reabsorption; UNaV, urinary sodium excretion; UosmV, urinary osmolar
clearance; UureaV, urinary urea clearance.
aPo0.001; bPo0.01; cPo0.05, HT vs CTL.
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Figure 1 | Urine production in HT (dashed line; n¼ 15) and control
(solid line; n¼ 12) rats. Urine volume was increased progressively in
the HT rats, whereas there was no change in urine production in
control rats. The differences in urine production between HT and
control rats became significant at day 12. *Po0.05.
Table 1 | Hemodynamics data on day 14 after thyroxine
treatment (protocol 1)
CTL (n=5) HT (n=6)
Heart rate (beats/min) 420716 530713a
Cardiac index (ml/min/100 g) 3378 5476b
MAP (mm Hg) 9975 11774c
Pulse pressure (mm Hg) 2372 3972a
Renal blood flow (ml/min) 5.270.6 8.170.5b
MAP, mean arterial pressure.
aPo0.001; bPo0.01; cPo0.05, HT vs CTL.
Kidney International (2007) 72, 1088–1094 1089
W Wang et al.: Polyuria in thyrotoxicosis o r i g i n a l a r t i c l e
and in the IM (8574 vs 10072% in controls, Po0.05,
Figure 3b) from HT rats.
Protocol 2. In the paired studies, abundance of AQP1
protein was also decreased in the cortex/OSOM (8773 vs
10071% in controls, Po0.05, Figure 4a), ISOM (7273 vs
10073% in controls, Po0.05, Figure 4b), and IM (7674 vs
10075% in controls, Po0.05, Figure 4c) in HT rats
compared with controls. Significant decreases were also seen
in AQP2 protein abundance in cortex/OSOM (7473 vs
10075% in controls, Po0.05, Figure 5a), in ISOM (8272 vs
10075% in controls, Po0.01, Figure 5b), and in IM (8075
vs 10074% in controls, Po0.001, Figure 5c) in rats as
compared with controls.
Vasopressin-receptor binding assay and intracellular cAMP
levels
Membranes from the renal papilla and cortex combined with
outer medulla in both HT and control rats in paired study
(protocol 2) were assayed for vasopressin V2 receptor by a
radiolabeled vasopressin-binding assay (Figure 6). In HT rats,
vasopressin binding was significantly increased compared
with controls in the IM (0.5370.05 vs 0.3670.03 in controls,
Po0.05) and cortex and outer medulla (combined)
(0.0470.004 vs 0.0270.003 in controls, Po0.05). cAMP
was measured in IM and cortex combined with outer medulla
from both groups. The cAMP level was significantly reduced
in the IM from HT rats compared with controls (2971.6 vs
3571.6 fmol/mg in controls, Po0.05); it did not change in
the cortex combined with outer medulla (2070.6 vs
2271 fmol/mg in controls, P40.05).
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Figure 2 | Semiquantitative immunoblots of AQP1 using kidney
proteins prepared from cortex/OSOM and IM of both CTL and HT
rats (protocol 1). HT rats showed a significant decrease in protein
abundance in (a) cortex/OSOM and (b) IM compared with CTL rats.
Western immunoblots shown are representative of blots performed
with a total sample size of n¼ 6 rats in CTL and n¼ 8 rats in HT
group. Densitometric results are expressed as a percentage
compared with the mean value in controls (100%).
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Figure 3 | Semiquantitative immunoblots of AQP2 using kidney
proteins prepared from ISOM and IM of both CTL and HT rats
(protocol 1). HT rats showed a significant decrease in protein
abundance in (a) ISOM and (b) IM compared with CTL rats. Western
immunoblots shown are representative of blots performed with a
total sample size of n¼ 6 rats in CTL and n¼ 8 rats in HT group.
Densitometric results are expressed as a percentage compared with
the mean value in controls (100%).
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Figure 4 | Semiquantitative immunoblots of AQP1 using kidney
proteins prepared from cortex/OSOM, ISOM, and IM of both CTL
and HT rats (protocol 2). HT rats showed a significant decrease in
protein abundance in (a) cortex/OSOM, (b) ISOM, and (c) IM
compared with CTL rats. Western immunoblots shown are
representative of blots performed with a total sample size of n¼ 6
rats in CTL and n¼ 7 rats in HT group. Densitometric results are
expressed as a percentage compared with the mean value in controls
(100%).
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Hyperthyroidism was associated with increased Na,K-ATPase,
Naþ /Hþ exchanger isoform 3, and Naþ–Kþ–2Cl cotran-
sporter abundance
Na, K-ATPase, Naþ /Hþ exchanger isoform 3 (NHE3), and
Naþ–Kþ–2Cl cotransporter (NKCC2) play important roles
in renal sodium reabsorption. We therefore examined
abundance of these sodium transporters in thyroxine-treated
rats. Hyperthyroidism was associated with a substantial
increase in Na, K-ATPase (a1-subunit), NHE3, and NKCC2
protein expression in the cortex/OSOM and ISOM in both
protocol 1 (Figures 7a–c) and protocol 2 (Figures 8a–c). These
changes in transporter abundances were accompanied by
increase in solute-free water reabsorption and urinary
sodium excretion (Tables 2 and 3).
DISCUSSION
The identification of renal water channels and ion transpor-
ters has allowed a better understanding of disorders of
urinary concentration and dilution.9 Our laboratory has
focused on understanding the physiological and molecular
basis of impaired water homeostasis in endocrinopathies,
including adrenal and thyroid disorders.10–13 Polyuria has
been described in thyroxicosis in human5 and animals,6 but
the mechanisms for this perturbation are still unclear.
In this study, the thyroxin-treated animals exhibited
systemic and renal hemodynamics that mimicked those
observed in patients with hyperthyroidism. As compared
with controls, the HT rats exhibited increased MAP, cardiac
index, heart rate, pulse pressure, and RBF. The HT rats also
demonstrated increased water intake and urine flow. These
HT animals ingested more food than euthyroid animals even
as they lost body weight, findings compatible with increased
catabolism. An osmotic diuresis occurred during hyperthyroi-
dism, including enhanced urinary sodium and urea excre-
tion. Therefore, the HT-associated polyuria, which has
been described in hyperthyroid patients,5,14 could be
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Figure 5 | Semiquantitative immunoblots of AQP2 using kidney
proteins prepared from cortex/OSOM, ISOM, and IM of both CTL
and HT rats (protocol 2). HT rats showed a significant decrease in
protein abundance in (a) CO/OSOM, (b) ISOM, and (c) IM compared
with CTL rats. Western immunoblots shown are representative of
blots performed with a total sample size of n¼ 6 rats in CTL and n¼ 7
rats in HT group. Densitometric results are expressed as a percentage
compared with the mean value in controls (100%).
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Figure 6 | Binding of vasopressin to IM and cortex combined with
outer medulla membranes in HT and controls rats. Significant
higher binding is detected in membranes from HT rats, compared
with controls.
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Figure 7 | Semiquantitative immunoblots of (a) Na,K-ATPase,
(b) NHE3, and (c) NKCC2 using kidney proteins prepared from
cortex/OSOM and ISOM of both CTL and HT rats (protocol 1).
HT rats showed significant increases in protein abundance in cortex/
OSOM and ISOM compared with CTL rats. Western immunoblots
shown are representative of blots performed with a total sample size
of n¼ 6 rats in CTL and n¼ 8 rats in HT group. Densitometric results
are expressed as a percentage compared with the mean value in
controls (100%). Solid bars¼ euthyroid; open bars¼ hyperthyroid.
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attributed, at least in part, to increased thirst and solute
diuresis.
Further studies were therefore undertaken in which HT
and control rats ingested the same amount of water and food.
In these studies, the HT rats continued to have polyuria in
association with increased sodium and urea excretion as
compared with euthyroid control animals. Thus, stimulation
of thirst seemed unlikely by itself to explain the polyuria
associated with thyrotoxicosis.
An increase in solute excretion, however, continued to be
observed in the pair-fed hyperthyroid rats, no doubt
secondary to enhanced catabolism. Because a solute diuresis
is known to increase urine flow, this appeared to be a factor
in the polyuria of hyperthyroidism independent of increased
solute intake. Of interest, this solute diuresis associated with
hyperthyroidism occurred in spite of a consistent increased
expression of several ion transporters including Na, K-
ATPase, NHE3, and NKCC2 in both the ad lib and paired
studies. This upregulation is compatible with a direct effect of
thyroid hormone on these ion transporters.8,15,16
The paradoxical observation of increased solute excretion
in the presence of the increased transporters is in need of
explanation. In that regard, the hyperthyroid-related altera-
tion in renal hemodynamics, specifically the increased renal
arterial pressure and decreased filtration fraction, would be
expected to decrease isotonic fluid reabsorption in the
proximal tubule, increase sodium and water delivery to the
distal nephron, and contribute to the solute diuresis,17–19 thus
overriding the increased ion transporters in thyroxicosis.
Of particular interest relative to the polyuria of hyperthyro-
idism was the downregulation of AQP1 and AQP2 water
channels in both the ad lib and paired studies. In AQP1
knockout mice polyuria secondary to vasopressin-resistant,
nephrogenic diabetes insipidus has been demonstrated.20
Moreover, a urinary concentrating defect has been described
in patients with a downregulation of AQP1 when they were
challenged by dehydration.21 AQP1 expression was reduced
in IM in thyroxicosis, suggesting that the most water-
permeable segment of the nephron may have reduced water
conductance, thereby contributing to the polyuria. The
observed decrease in AQP1 in the hyperthyroid rats, however,
may not be comparable with the patients who are null for
AQP1. With decreased AQP1, the resultant increased distal
delivery to the macula densa might alter the sensitivity of the
tubular glomerular feedback mechanism.22
The observed decrease in AQP2 expression in the outer
and IM is quite relevant with respect to the polyuria of
hyperthyroidism. This protein is the main water channel in
the apical membrane of principal cells in the collecting duct
and the transcription-regulated expression of AQP2 is
primarily mediated by AVP. In the ad lib study, the
downregulation of AQP2 expression, however, was not
associated with a detectable suppression of plasma AVP.
Moreover, in the paired study, the negative water balance in
the hyperthyroid rats, secondary to polyuria and water intake
controlled to the same amount as euthyroid controls, was
associated with increased plasma AVP. Thus, in neither the
ad lib nor paired water studies, was adversely the down-
regulation of AQP1 and AQP2 associated with a suppression
of plasma AVP.
There is previous evidence indicating vasopressin-inde-
pendent modulation of AQP2. For example, there are
in vitro23,24 and in vivo25 results demonstrating the effect of
hypertonicity to upregulate AQP2 expression. More relevant
to hyperthyroidism, however, are recent results indicating
that acute hypertension induced by either angiotensin II or
norepinephrine, reduced medullary AQP2 abundance.26 In
this regard, hypertension is a consistent feature of thyrotoxi-
cosis in humans2 and in the hyperthyroid rat model used in
this study. The mechanism that hypertension downregulates
AQP2 is not known. Of interest, however, in this study, renal
cyclic AMP was decreased in spite of an increase in AVP
binding in the thyrotoxic rats. This effect could be due to
reduced adenyl cyclase or increased phosphodiesterase
activity and is in need of further study.
Another interesting finding in this study was the increase
in solute-free water reabsorption (TcH2O) in both ad lib and
paired studies. Quantitatively, larger volumes of solute-free
water are reabsorbed in the distal nephron before the
collecting duct, yet the final regulation of water excretion
occurs in the collecting duct. Therefore, the enhanced
Na–K–2Cl and Na–K–ATPase secondary to increased thyroid
hormone are compatible with enhanced solute-free water
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Figure 8 | Semiquantitative immunoblots of (a) Na,K-ATPase,
(b) NHE3, and (c) NKCC2 using kidney proteins prepared from
cortex/OSOM and ISOM of both CTL and HT rats (protocol 2).
HT rats showed significant increases in protein abundance in cortex/
OSOM and ISOM compared with CTL rats. Western immunoblots
shown are representative of blots performed with a total sample size
of n¼ 6 rats in CTL and n¼ 7 rats in HT group. Densitometric results
are expressed as a percentage compared with the mean value in
controls (100%). Solid bars¼ euthyroid; open bars¼ hyperthyroid.
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reabsorption in the presence of polyuria associated with
downregulation of AQP2 expression in the principal cells of
the collecting duct.
In conclusion, the polyuria associated with hyperthyroid-
ism is associated with increased water and solute intake;
however, it may occur in the absence of increased water and
solute intake. Although thyroid hormone treatment upregu-
lated ion transporters and increased solute-free water
reabsorption, vasopressin-independent downregulation of
AQP2 in the collecting duct was associated with the polyuria.
Downregulation of AQP1 was also found in hyperthyroid-
ism-related polyuria. The downregulation of AQP2 and
AQP1 water channels and increased solute excretion account
for the polyuria associated with hyperthyroidism. The
hypertension, and thus increased renal arterial pressure, as
well as the decrease in filtration fraction with thyrotoxicosis,
provide an explanation for the paradoxical solute diuresis in
spite of enhanced ion transporters in the thyrotoxic animals.
MATERIALS AND METHODS
Experimental animals
The study protocol was approved by the University of Colorado
Institutional Animal Care and Use Committee. Male Wistar rats
(180–220 g body weight) were allowed to acclimate to Denver, CO,
altitude (1500 m) for 4 days before the experimental protocols. All
animals were acclimatized to metabolic cages for a continuous 2-day
period before initiation of study. The animals were housed
individually in metabolic cages for entire experimental period and
exposed to a 12:12 h light–dark cycle and constant ambient
temperature. Body weight, daily water intake, urinary volume, and
food intake were monitored.
Protocol 1. Rats were divided randomly into two study groups:
hyperthyroidism (HT) (n¼ 15) and control (CTL, n¼ 12).
Hyperthyroidism was induced by daily intraperitoneal injection of
thyroxine 200 mg/kg/day dissolved in isotonic NaOH saline for 2
weeks. The last injection (100 mg/kg) was given 12 h before killing.
All rats had free access to plain powdered rat food (0.23% sodium
Harlan Teklad Bioproducts, Indianapolis, IN) and tap water.
Protocol 2. The animals underwent the same thyroid treatment
as described for protocol 1. To exclude the effects of more food and
water intake in HT rats, all rats were pair-fed and the amount of
water given to HT rats (n¼ 12) was restricted to same daily
consumption of control rats (n¼ 15). Some rats (HT n¼ 8, CTL
n¼ 6) were used for RBF measurement, vasopressin-binding assay,
and cAMP measurements.
At the end of protocols 1 and 2, all rats were killed by
decapitation. Trunk blood was collected for measurement of plasma
AVP concentration and for measurement of serum osmolality,
sodium, creatinine, and blood urea nitrogen concentrations. For
each animal, one kidney was rapidly removed and dissected into
cortex/OSOM, ISOM, and IM and was processed for membrane
fractionation and semiquantitative immunoblotting.
Echocardiography and measurement of RBF and MAP
For protocol 1, 11 rats underwent echocardiography and RBF and
MAP measurements. Echocardiography was performed in both HT
and control rats using a GE Vingmed System Five imaging tool for
small rodents with a 10-MHz probe. The animals were anesthetized
with ketamine (40 mg/kg body weight intraperitoneally) and
xylazine (5 mg/kg body weight intraperitoneally). The left ventri-
cular fraction of shortening was calculated from left ventricular
systolic (LVIDs) and diastolic (LVIDd) diameter as ((LVIDdL-
VIDs)/LVIDd) 100%. Cardiac output was calculated via measure-
ment of the diameter of the outflow tract (LVOT), the flow through
the ventricular outflow tract (VTI), and the heart rate (HR) by the
formula 0.785 LVOT2VTIHR. The cardiac index was re-
ported as cardiac output per 100 g of body weight. MAP was
measured via a carotid artery catheter connected to a Transpac IV
transducer and monitored continuously using Windaq Waveform
recording software (Dataq Instruments, Akron, OH, USA). For RBF
measurement, the kidney was exposed by a left subcostal incision
and was dissected free from perirenal tissue, and renal arteries were
isolated for the determination using a blood flowmeter and probe
(0.5v; Transonic Systems, Ithaca, NY).
Biochemical measurements
Plasma AVP concentration was assessed by radioimmunoassay as
described previously.27 Serum and urinary osmolality were mea-
sured by freezing-point depression (Advanced Instruments, Nor-
wood, MA). Serum and urinary creatinine and urea were measured
(Beckman Instruments, Fullerton, CA). Creatinine clearance at 24 h
was used as an estimate of glomerular filtration rate. Serum Naþ
concentration was measured by flame photometry.
Antibodies
Antibodies to AQP2,28 NHE3,29 NKCC230 have been characterized
previously. Anti-Naþ , Kþ -ATPase a1-subunit antibody was ob-
tained from Upstate Biotechnology (Lake Placid, NY). Anti-AQP1
antibody was obtained from Chemicon International (Temecula,
CA).
Protein isolation
Kidneys were placed in ice-cold isolation solution containing
250 mM sucrose, 25 mM imidazole, and 1 mM EDTA (pH 7.2) with
0.1 vol% protease inhibitors (0.7 mg/ml pepstatin, 0.5mg/ml
leupeptin, and 1 mg/ml aprotinin) and 200 mM phenylmethylsulfonyl
fluoride. As noted above, kidneys were dissected on ice into cortex/
OSOM, ISOM, and IM. Tissue samples were immediately homo-
genized in a glass homogenizer at 41C. After homogenization,
protein concentration was determined for each sample by the
Bradford method (Bio-Rad, Richmond, CA). Tissue protein was
utilized for immunoblotting for AQP water channels and Naþ
transporters.
Western blot analysis
Sodium dodecyl sulfate polyacrylamide gel elecrophoresis was
performed on 4–12% acrylamide gradient gels for NKCC2 and on
12% acrylamide gels for AQPs, NHE3, and Naþ , Kþ -ATPase a1-
subunit proteins. After transfer by electroelution to polyvinylidene
difluoride membranes (Millipore, Bedford, MA), the blots were
blocked with 5% nonfat dry milk in phosphate-buffered saline and
then probed with the respective antibodies at 41C overnight. The
membranes were washed with buffer containing phosphate-buffered
saline with 0.1% Tween 20 (J.T. Baker, Phillipsburg, NJ) and then
exposed to secondary antibody for 1 h at room temperature.
Subsequent detection of the specific proteins was carried out by
enhanced chemiluminescence (Amersham, Arlington Heights, IL)
according to the manufacturer’s instructions. Densitometric results
were reported as integrated values (area density of band) and
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expressed as a percentage compared with the mean value in controls
(100%). Blots are representative of results obtained from all samples.
Densitometry reflects means7s.e. of all samples.
Vasopressin-binding assay and cAMP measurement
A vasopressin-binding assay was performed on membranes prepared
from IM and cortex and outer medulla (combined) as described
previously with slight modifications.31,32 Renal medullary and
cortical tissues were homogenized in homogenizing solution
(0.32 M sucrose, 5 mM Tris–HCl, 2 mM EDTA, 0.1 mM phenylmethyl-
sulfonyl fluoride, pH 7.4). After the homogenization, the samples
were centrifuged twice at 1000 g for 10 min at 41C. The supernatants
were then centrifuged at 100 000 g for 60 min at 41C, and the pellets
were suspended in the ice-cold binding buffer (50 mM Tris–HCl (pH
7.4), 5 mM MgCl2, 1 mg/ml bovine serum albumin). Each membrane
preparation were incubated for 15 min at 301C in 150 ml of medium
containing 50 mM Tris–HCl (pH 7.4), 0.75 mM MgCl2, 0.25 mM
EDTA, 1 mg/ml BSA, and 9.5 nM [3H]vasopressin ([3H]AVP, 44 Ci/
mmol; New England Nuclear, PerkinElmer, Boston, MA, USA).
Nonspecific binding was determined in the presence of 10 mM
unlabeled vasopressin (AVP; Sigma, St Louis, MO, USA). The
incubation was followed immediately by centrifugation at 10 000 g
for 20 min at 41C. The pellet was rinsed with 200ml of cold assay
buffer and solubilized in 100 ml of 0.1 N NaOH. Receptor-bound
radioactivity was measured by liquid scintillation spectrometry. This
method does not provide values for Kd and Vmax for AVP binding.
All assays were performed on duplicate samples. cAMP was
measured according to cAMP [125I] Biotrak Assay Kit (Amersham,
NJ, USA).
Statistical methods
Statistical analysis of results was performed using the unpaired
t-test. Values are means7s.e. Po0.05 was considered significant.
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